Healx
Healx identifies existing drugs that could treat rare diseases, offering a cost effective way to improve patient quality of life
- This event has passed.
BIO Partnering at JPM
Will we see you at the BIO Partnering event as part of JP Morgan week? If you’re interested in discussing opportunities for co-development of rare disease treatments or the out-licensing your drug repurposing assets then we’d be delighted to arrange a time to meet.
During the conference you’ll be able to catch up with the following team members:
- Dr Bruce Bloom – Chief Collaboration Officer
- Eugenia Wachters, MBA – VP Commercial Portfolio Strategy
- Dr Clara Tang – Business Manager, Early Commercial Strategy
Please get in touch with a member of our team via the partnering platform to schedule a meeting. For all other enquiries please click here to contact us. We look forward to seeing you there!